Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

Innovative devices offer hope for improved stroke therapy

Oct. 1, 2002

By Larry Haimovitch

Innovative devices offer hope for improved stroke therapy

Sep. 1, 2002

By Larry Haimovitch

OmniSonics, Quinton outline therapeutic, financial progress

Sep. 1, 2002

By Larry Haimovitch

'Golden age' brings more improvements in cataract surgery

July 1, 2002

By Larry Haimovitch

Role of new heart failure devices debated by electrophysiologist

June 1, 2002

By Larry Haimovitch

CHF impact on large patient pool spells opportunity for device firms

Aug. 1, 2001

By Larry Haimovitch

Mixed trial results fuel controversy over ICD-pacing device

July 1, 2001

By Larry Haimovitch

Controversy aside, sizable market opportunity exists in TMR, PTMR

July 1, 2001

By Larry Haimovitch

Temperature management moves to forefront as stroke treatment

June 1, 2001

By Larry Haimovitch

Coronary 're-dos' still a major frustration to interventionalists

Dec. 1, 2000

By Larry Haimovitch

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...